Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

BUY
$1.37 - $3.4 $120 - $299
88 New
88 $0
Q1 2023

May 02, 2023

BUY
$5.52 - $9.23 $121 - $203
22 New
22 $0
Q3 2022

Nov 07, 2022

BUY
$13.43 - $18.74 $402 - $562
30 New
30 $0
Q2 2022

Aug 03, 2022

SELL
$10.26 - $20.81 $151,848 - $307,988
-14,800 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$11.53 - $19.97 $170,644 - $295,556
14,800 New
14,800 $296,000

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $36M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.